Bioverativ Inc. 4/A
4/A · Bioverativ Inc. · Filed Mar 27, 2017
Insider Transaction Report
Form 4/AAmended
Bioverativ Inc.BIVV
Celona Lucia
EVP, HR & Corp Commun. Officer
Transactions
- Award
Non-Qualified Stock Option
2017-02-14+14,899→ 14,899 totalExercise: $44.51Exp: 2027-02-14→ Common Stock (14,899 underlying) - Award
Non-Qualified Stock Option
2017-02-14+59,595→ 59,595 totalExercise: $44.51Exp: 2027-02-14→ Common Stock (59,595 underlying) - Award
Non-Qualified Stock Option
2017-02-14+29,797→ 29,797 totalExercise: $44.51Exp: 2027-02-14→ Common Stock (29,797 underlying)
Footnotes (3)
- [F1]The number of derivative securities acquired, the amount or number of shares and the number of derivative securities beneficially owned following the reported transaction have been amended from the original filing.
- [F2]This option vests in three equal annual installments beginning on February 14, 2018.
- [F3]This option vests in full on the third anniversary of the date of grant.